全体要約
2023年の世界の嚢胞性線維症診断検査市場は、数百万米ドルの価値があると推定され、2030年までに同様の規模に調整される見込みです。市場は、遺伝子検査、糞便検査、免疫反応性トリプシノーゲン(IRT)検査、汗塩素検査、肺機能検査などのタイプに分かれています。主なアプリケーションには、病院、診断ラボなどがあります。
市場は、北米、欧州、アジア太平洋、ラテンアメリカ、中東・アフリカの地域に分かれ、各地域の市場規模と発展可能性が分析されています。主要企業には、Quidel Corporation、Quest Diagnostics、Illuminaなどが含まれ、競争環境や市場シェアも詳細に分析されています。
関連する質問
Quidel Corporation, Quest Diagnostics, Creative Diagnostics, Invitae Corporation, Asper Biogene, GeneDx, Illumina, Elucigene Diagnostics, BillionToOne Inc., ELITechGroup
医療需要の増加, 技術革新, 慢性疾患の有病率の上昇
概要
2022年の世界の製薬市場は1475億ドルで、今後6年間で年平均成長率(CAGR)5%で成長する見込みです。製薬市場には、化学薬品と生物学的薬品が含まれます。生物学的製剤は2022年には3810億ドルに達すると予想されています。それに対して、化学薬品市場は2018年の1005億ドルから2022年には1094億ドルに増加すると推定されています。製薬市場の要因には、ヘルスケアへの需要の増加、技術の進歩、慢性疾患の罹患率の上昇、製薬製造セグメントの開発のための民間および政府機関からの資金増加、そして薬の研究開発活動の増加が含まれます。しかし、業界は厳格な規制、高い研究開発コスト、特許の期限切れといった課題にも直面しています。企業は競争力を維持し、製品が必要な患者のもとに届くようにするために、絶えず革新し、これらの課題に適応する必要があります。さらに、COVID-19パンデミックはワクチン開発とサプライチェーン管理の重要性を強調し、製薬企業が新たな公衆衛生上のニーズに敏感かつ迅速に対応する必要性をさらに強調しました。
レポートの範囲
この報告書は、全体的な売上収益、主要企業の市場シェアおよびランキングに焦点を当てながら、地域別および国別、タイプ別、アプリケーション別の嚢胞性線維症診断テストの分析を提供することを目的としています。
嚢胞性線維症診断テスト市場の規模、推定、予測は、2023年を基準年とし、2019年から2030年までの期間にわたる販売収益(百万ドル)で提供されています。定量的および定性的分析を通じて、読者がビジネス/成長戦略を策定し、市場の競争状況を評価し、現在の市場における自社の立ち位置を分析し、嚢胞性線維症診断テストに関する情報に基づいたビジネス決定を行うための支援をします。
市場セグメンテーション
会社別
クイデル社
クエスト・ダイアグノスティクス
クリエイティブダイアグノスティクス
インビテイ社
アスパー・バイオジーン
ジーンデックス
イルミナ
エルシジーン診断
ビリオンツーオネ株式会社
ELITechGroup
タイプ別セグメント:
遺伝子検査
検便検査
免疫反応性トリプシノーゲン(IRT)テスト
汗塩素検査
肺機能検査
アプリケーション別セグメント
病院
診断ラボラトリー
その他
地域別
北アメリカ
アメリカ合衆国
カナダ
ヨーロッパ
ドイツ
フランス
イギリス
イタリア
ロシア
アジア太平洋
中国
日本
韓国
中国 台湾
東南アジア
インド
ラテンアメリカ
メキシコ
ブラジル
アルゼンチン
中東およびアフリカ
トルコ
サウジアラビア
アラブ首長国連邦
章の概要
第1章: レポートの範囲、世界の総市場規模を紹介します。この章では、マーケットダイナミクス、市場の最新の発展、市場の推進要因と制約要因、業界のメーカーが直面する課題とリスク、そして業界に関連する政策の分析も提供します。
第2章: 嚢胞性線維症診断テスト製造業者の競争状況の詳細分析、収益市場シェア、最新の開発計画、合併・買収情報など。
第3章:各市場セグメントのタイプ別の分析を提供し、各市場セグメントの市場規模と発展の可能性をカバーしています。これにより、読者は異なる市場セグメントでブルーオーシャン市場を見つける手助けをします。
第4章:さまざまな市場セグメントの分析を提供し、アプリケーション別に各市場セグメントの市場規模および発展可能性を概説します。これにより、読者は異なる下流市場におけるブルーオーシャン市場を見つける手助けをします。
第5章:地域レベルにおける嚢胞性線維症診断テストの収益。各地域の市場規模と発展可能性の定量分析を提供し、世界の各国の市場の発展、将来の発展見通し、市場スペース、および市場規模を紹介します。
第6章: 国別の嚢胞性線維症診断テストの収益です。各国/地域における種類別および用途別のシグマテデータを提供します。
第7章:主要プレーヤーのプロフィールを提供し、市場における主要企業の基本的な状況を詳細に紹介します。これには、製品収益、粗利益、製品紹介、最近の開発などが含まれます。
第8章: 産業チェーンの分析、業界の上流と下流を含む。
第9章: 結論。
※以下の目次にて、具体的なレポートの構成をご覧頂けます。ご購入、無料サンプルご請求、その他お問い合わせは、ページ上のボタンよりお進みください。
目次
1 市場概要
1.1 嚢胞性線維症診断検査 : プロダクトのイントロダクション
1.2 グローバルの市場規模、市場予測
1.3 嚢胞性線維症診断検査市場トレンドと成長ドライバー
1.3.1 嚢胞性線維症診断検査業界トレンド
1.3.2 嚢胞性線維症診断検査市場のドライバーと事業機会
1.3.3 嚢胞性線維症診断検査市場の課題
1.3.4 嚢胞性線維症診断検査市場の抑制要因
1.4 前提条件と限界
1.5 調査の目的
1.6 対象年
2 競合分析、企業別
2.1 グローバルの嚢胞性線維症診断検査、プレイヤー収益ランキング(2023年)
2.2 グローバルにおける嚢胞性線維症診断検査市場の収益規模、企業別(2019年~2024年)
2.3 嚢胞性線維症診断検査の主要企業、製造・販売拠点およびヘッドクオーター
2.4 嚢胞性線維症診断検査の主要企業、製品展開
2.5 嚢胞性線維症診断検査の主要企業、量産開始時期
2.6 嚢胞性線維症診断検査市場の競争状況分析
2.6.1 嚢胞性線維症診断検査市場集中度比率(2019年~2024年)
2.6.2 グローバルの嚢胞性線維症診断検査、上位企業5~10社の収益(2023年)
2.6.3 グローバルの嚢胞性線維症診断検査、Tier別上位企業(Tier 1、Tier 2、Tier 3)、2023年の収益ベース
2.7 M&A、拡大
3 セグメンテーション、タイプ別
3.1 イントロダクション、タイプ別
3.1.1 遺伝子検査
3.1.2 糞便検査
3.1.3 免疫反応性トリプシノーゲン(IRT)検査
3.1.4 汗の塩化物検査
3.1.5 肺機能検査
3.2 グローバルの嚢胞性線維症診断検査の売上規模、金額ベース、タイプ別
3.2.1 グローバルの嚢胞性線維症診断検査の売上規模、金額ベース、タイプ別(2019年、2023年、2030年)
3.2.2 グローバルの嚢胞性線維症診断検査の売上規模、金額ベース、タイプ別(2019年~2030年)
3.2.3 グローバルの嚢胞性線維症診断検査の売上規模、金額ベース、タイプ別(%)(2019年~2030年)
4 セグメンテーション、用途別
4.1 イントロダクション、用途別
4.1.1 病院
4.1.2 検査室
4.1.3 その他
4.2 グローバルの嚢胞性線維症診断検査の売上規模、金額ベース、用途別
4.2.1 グローバルの嚢胞性線維症診断検査の売上規模、金額ベース、用途別(2019年、2023年、2030年)
4.2.2 グローバルの嚢胞性線維症診断検査の売上規模、金額ベース、用途別(2019年~2030年)
4.2.3 グローバルの嚢胞性線維症診断検査の売上規模、金額ベース、用途別(%)(2019年~2030年)
5 セグメンテーション、地域別
5.1 グローバルの嚢胞性線維症診断検査の売上規模、金額ベース、地域別
5.2 北米
5.2.1 北米の嚢胞性線維症診断検査売上規模、金額ベース、2019年~2030年
5.2.2 北米の嚢胞性線維症診断検査の売上規模、金額ベース、国別(%)、2023年、2030年
5.3 ヨーロッパ
5.3.1 ヨーロッパの嚢胞性線維症診断検査売上規模、金額ベース、2019年~2030年
5.3.2 ヨーロッパの嚢胞性線維症診断検査の売上規模、金額ベース、国別(%)、2023年、2030年
5.4 アジア太平洋
5.4.1 アジア太平洋の嚢胞性線維症診断検査売上規模、金額ベース、2019年~2030年
5.4.2 アジア太平洋の嚢胞性線維症診断検査の売上規模、金額ベース、国別(%)、2023年、2030年
5.5 南米
5.5.1 南米の嚢胞性線維症診断検査売上規模、金額ベース、2019年~2030年
5.5.2 南米の嚢胞性線維症診断検査の売上規模、金額ベース、国別(%)、2023年、2030年
5.6 中東・アフリカ
5.6.1 中東・アフリカの嚢胞性線維症診断検査売上規模、金額ベース、2019年~2030年
5.6.2 中東・アフリカの嚢胞性線維症診断検査の売上規模、金額ベース、国別(%)、2023年、2030年
6 主要国・地域によるセグメンテーション
6.1 主要国・地域の嚢胞性線維症診断検査の売上成長トレンド、金額ベース(2019年、2023年、2030年)
6.2 主要国・地域の嚢胞性線維症診断検査の売上、金額ベース
6.3 米国
6.4 ヨーロッパ
6.5 中国
6.6 日本
6.7 韓国
6.8 東南アジア
6.9 インド
7 企業プロファイル
7.1 Quidel Corporation
7.1.1 Quidel Corporation : プロファイル
7.1.2 Quidel Corporation : 主な事業
7.1.3 Quidel Corporation : 嚢胞性線維症診断検査の製品、サービス、ソリューション
7.1.4 Quidel Corporation : 嚢胞性線維症診断検査の収益(百万米ドル)(2019年~2024年)
7.1.5 Quidel Corporation:近況
7.2 Quest Diagnostics
7.2.1 Quest Diagnostics : プロファイル
7.2.2 Quest Diagnostics : 主な事業
7.2.3 Quest Diagnostics : 嚢胞性線維症診断検査の製品、サービス、ソリューション
7.2.4 Quest Diagnostics : 嚢胞性線維症診断検査の収益(百万米ドル)(2019年~2024年)
7.2.5 Quest Diagnostics:近況
7.3 Creative Diagnostics
7.3.1 Creative Diagnostics : プロファイル
7.3.2 Creative Diagnostics : 主な事業
7.3.3 Creative Diagnostics : 嚢胞性線維症診断検査の製品、サービス、ソリューション
7.3.4 Creative Diagnostics : 嚢胞性線維症診断検査の収益(百万米ドル)(2019年~2024年)
7.3.5 Invitae Corporation:近況
7.4 Invitae Corporation
7.4.1 Invitae Corporation : プロファイル
7.4.2 Invitae Corporation : 主な事業
7.4.3 Invitae Corporation : 嚢胞性線維症診断検査の製品、サービス、ソリューション
7.4.4 Invitae Corporation : 嚢胞性線維症診断検査の収益(百万米ドル)(2019年~2024年)
7.4.5 Invitae Corporation:近況
7.5 Asper Biogene
7.5.1 Asper Biogene : プロファイル
7.5.2 Asper Biogene : 主な事業
7.5.3 Asper Biogene : 嚢胞性線維症診断検査の製品、サービス、ソリューション
7.5.4 Asper Biogene : 嚢胞性線維症診断検査の収益(百万米ドル)(2019年~2024年)
7.5.5 Asper Biogene:近況
7.6 GeneDx
7.6.1 GeneDx : プロファイル
7.6.2 GeneDx : 主な事業
7.6.3 GeneDx : 嚢胞性線維症診断検査の製品、サービス、ソリューション
7.6.4 GeneDx : 嚢胞性線維症診断検査の収益(百万米ドル)(2019年~2024年)
7.6.5 GeneDx:近況
7.7 Illumina
7.7.1 Illumina : プロファイル
7.7.2 Illumina : 主な事業
7.7.3 Illumina : 嚢胞性線維症診断検査の製品、サービス、ソリューション
7.7.4 Illumina : 嚢胞性線維症診断検査の収益(百万米ドル)(2019年~2024年)
7.7.5 Illumina:近況
7.8 Elucigene Diagnostics
7.8.1 Elucigene Diagnostics : プロファイル
7.8.2 Elucigene Diagnostics : 主な事業
7.8.3 Elucigene Diagnostics : 嚢胞性線維症診断検査の製品、サービス、ソリューション
7.8.4 Elucigene Diagnostics : 嚢胞性線維症診断検査の収益(百万米ドル)(2019年~2024年)
7.8.5 Elucigene Diagnostics:近況
7.9 BillionToOne Inc
7.10 ELITechGroup
7.10.1 ELITechGroup : プロファイル
7.10.2 ELITechGroup : 主な事業
7.10.3 ELITechGroup : 嚢胞性線維症診断検査の製品、サービス、ソリューション
7.10.4 ELITechGroup : 嚢胞性線維症診断検査の収益(百万米ドル)(2019年~2024年)
7.10.5 ELITechGroup:近況
8 業界チェーン分析
8.1 嚢胞性線維症診断検査業界バリューチェーン
8.2 嚢胞性線維症診断検査市場の上流分析
8.2.1 主要原材料
8.2.2 原材料と主要サプライヤー
8.2.3 製造コスト構造
8.3 中流分析
8.4 下流分析(顧客についての分析)
8.5 営業販売モデル、販売チャネル
8.5.1 嚢胞性線維症診断検査 営業販売モデル
8.5.2 販売チャネル
8.5.3 嚢胞性線維症診断検査の流通業者
9 調査の結果・結論
10 付録
10.1 調査手法
10.1.1 調査手法 / 調査アプローチ
10.1.2 データソース
10.2 執筆者の詳細
10.3 免責事項
※英文のレポートについての日本語表記のタイトルや紹介文などは、すべて生成AIや自動翻訳ソフトを使用して提供しております。それらはお客様の便宜のために提供するものであり、当社はその内容について責任を負いかねますので、何卒ご了承ください。適宜英語の原文をご参照ください。
“All Japanese titles, abstracts, and other descriptions of English-language reports were created using generative AI and/or machine translation. These are provided for your convenience only and may contain errors and inaccuracies. Please be sure to refer to the original English-language text. We disclaim all liability in relation to your reliance on such AI-generated and/or machine-translated content.”
Description
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Cystic Fibrosis Diagnostic Tests, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Cystic Fibrosis Diagnostic Tests by region & country, by Type, and by Application.
The Cystic Fibrosis Diagnostic Tests market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cystic Fibrosis Diagnostic Tests.
Market Segmentation
By Company
Quidel Corporation
Quest Diagnostics
Creative Diagnostics
Invitae Corporation
Asper Biogene
GeneDx
Illumina
Elucigene Diagnostics
BillionToOne Inc.
ELITechGroup
Segment by Type:
Genetic Tests
Fecal Test
Immunoreactive Trypsinogen (IRT) Test
Sweat Chloride Tests
Pulmonary Function Tests
Segment by Application
Hospitals
Diagnostic Laboratories
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Cystic Fibrosis Diagnostic Tests manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Cystic Fibrosis Diagnostic Tests in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Cystic Fibrosis Diagnostic Tests in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
Table of Contents
1 Market Overview
1.1 Cystic Fibrosis Diagnostic Tests Product Introduction
1.2 Global Cystic Fibrosis Diagnostic Tests Market Size Forecast
1.3 Cystic Fibrosis Diagnostic Tests Market Trends & Drivers
1.3.1 Cystic Fibrosis Diagnostic Tests Industry Trends
1.3.2 Cystic Fibrosis Diagnostic Tests Market Drivers & Opportunity
1.3.3 Cystic Fibrosis Diagnostic Tests Market Challenges
1.3.4 Cystic Fibrosis Diagnostic Tests Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Cystic Fibrosis Diagnostic Tests Players Revenue Ranking (2023)
2.2 Global Cystic Fibrosis Diagnostic Tests Revenue by Company (2019-2024)
2.3 Key Companies Cystic Fibrosis Diagnostic Tests Manufacturing Base Distribution and Headquarters
2.4 Key Companies Cystic Fibrosis Diagnostic Tests Product Offered
2.5 Key Companies Time to Begin Mass Production of Cystic Fibrosis Diagnostic Tests
2.6 Cystic Fibrosis Diagnostic Tests Market Competitive Analysis
2.6.1 Cystic Fibrosis Diagnostic Tests Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Cystic Fibrosis Diagnostic Tests Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cystic Fibrosis Diagnostic Tests as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Genetic Tests
3.1.2 Fecal Test
3.1.3 Immunoreactive Trypsinogen (IRT) Test
3.1.4 Sweat Chloride Tests
3.1.5 Pulmonary Function Tests
3.2 Global Cystic Fibrosis Diagnostic Tests Sales Value by Type
3.2.1 Global Cystic Fibrosis Diagnostic Tests Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Cystic Fibrosis Diagnostic Tests Sales Value, by Type (2019-2030)
3.2.3 Global Cystic Fibrosis Diagnostic Tests Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospitals
4.1.2 Diagnostic Laboratories
4.1.3 Others
4.2 Global Cystic Fibrosis Diagnostic Tests Sales Value by Application
4.2.1 Global Cystic Fibrosis Diagnostic Tests Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Cystic Fibrosis Diagnostic Tests Sales Value, by Application (2019-2030)
4.2.3 Global Cystic Fibrosis Diagnostic Tests Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Cystic Fibrosis Diagnostic Tests Sales Value by Region
5.1.1 Global Cystic Fibrosis Diagnostic Tests Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Cystic Fibrosis Diagnostic Tests Sales Value by Region (2019-2024)
5.1.3 Global Cystic Fibrosis Diagnostic Tests Sales Value by Region (2025-2030)
5.1.4 Global Cystic Fibrosis Diagnostic Tests Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Cystic Fibrosis Diagnostic Tests Sales Value, 2019-2030
5.2.2 North America Cystic Fibrosis Diagnostic Tests Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Cystic Fibrosis Diagnostic Tests Sales Value, 2019-2030
5.3.2 Europe Cystic Fibrosis Diagnostic Tests Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Cystic Fibrosis Diagnostic Tests Sales Value, 2019-2030
5.4.2 Asia Pacific Cystic Fibrosis Diagnostic Tests Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Cystic Fibrosis Diagnostic Tests Sales Value, 2019-2030
5.5.2 South America Cystic Fibrosis Diagnostic Tests Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Cystic Fibrosis Diagnostic Tests Sales Value, 2019-2030
5.6.2 Middle East & Africa Cystic Fibrosis Diagnostic Tests Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Cystic Fibrosis Diagnostic Tests Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Cystic Fibrosis Diagnostic Tests Sales Value
6.3 United States
6.3.1 United States Cystic Fibrosis Diagnostic Tests Sales Value, 2019-2030
6.3.2 United States Cystic Fibrosis Diagnostic Tests Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Cystic Fibrosis Diagnostic Tests Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Cystic Fibrosis Diagnostic Tests Sales Value, 2019-2030
6.4.2 Europe Cystic Fibrosis Diagnostic Tests Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Cystic Fibrosis Diagnostic Tests Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Cystic Fibrosis Diagnostic Tests Sales Value, 2019-2030
6.5.2 China Cystic Fibrosis Diagnostic Tests Sales Value by Type (%), 2023 VS 2030
6.5.3 China Cystic Fibrosis Diagnostic Tests Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Cystic Fibrosis Diagnostic Tests Sales Value, 2019-2030
6.6.2 Japan Cystic Fibrosis Diagnostic Tests Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Cystic Fibrosis Diagnostic Tests Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Cystic Fibrosis Diagnostic Tests Sales Value, 2019-2030
6.7.2 South Korea Cystic Fibrosis Diagnostic Tests Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Cystic Fibrosis Diagnostic Tests Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Cystic Fibrosis Diagnostic Tests Sales Value, 2019-2030
6.8.2 Southeast Asia Cystic Fibrosis Diagnostic Tests Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Cystic Fibrosis Diagnostic Tests Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Cystic Fibrosis Diagnostic Tests Sales Value, 2019-2030
6.9.2 India Cystic Fibrosis Diagnostic Tests Sales Value by Type (%), 2023 VS 2030
6.9.3 India Cystic Fibrosis Diagnostic Tests Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Quidel Corporation
7.1.1 Quidel Corporation Profile
7.1.2 Quidel Corporation Main Business
7.1.3 Quidel Corporation Cystic Fibrosis Diagnostic Tests Products, Services and Solutions
7.1.4 Quidel Corporation Cystic Fibrosis Diagnostic Tests Revenue (US$ Million) & (2019-2024)
7.1.5 Quidel Corporation Recent Developments
7.2 Quest Diagnostics
7.2.1 Quest Diagnostics Profile
7.2.2 Quest Diagnostics Main Business
7.2.3 Quest Diagnostics Cystic Fibrosis Diagnostic Tests Products, Services and Solutions
7.2.4 Quest Diagnostics Cystic Fibrosis Diagnostic Tests Revenue (US$ Million) & (2019-2024)
7.2.5 Quest Diagnostics Recent Developments
7.3 Creative Diagnostics
7.3.1 Creative Diagnostics Profile
7.3.2 Creative Diagnostics Main Business
7.3.3 Creative Diagnostics Cystic Fibrosis Diagnostic Tests Products, Services and Solutions
7.3.4 Creative Diagnostics Cystic Fibrosis Diagnostic Tests Revenue (US$ Million) & (2019-2024)
7.3.5 Invitae Corporation Recent Developments
7.4 Invitae Corporation
7.4.1 Invitae Corporation Profile
7.4.2 Invitae Corporation Main Business
7.4.3 Invitae Corporation Cystic Fibrosis Diagnostic Tests Products, Services and Solutions
7.4.4 Invitae Corporation Cystic Fibrosis Diagnostic Tests Revenue (US$ Million) & (2019-2024)
7.4.5 Invitae Corporation Recent Developments
7.5 Asper Biogene
7.5.1 Asper Biogene Profile
7.5.2 Asper Biogene Main Business
7.5.3 Asper Biogene Cystic Fibrosis Diagnostic Tests Products, Services and Solutions
7.5.4 Asper Biogene Cystic Fibrosis Diagnostic Tests Revenue (US$ Million) & (2019-2024)
7.5.5 Asper Biogene Recent Developments
7.6 GeneDx
7.6.1 GeneDx Profile
7.6.2 GeneDx Main Business
7.6.3 GeneDx Cystic Fibrosis Diagnostic Tests Products, Services and Solutions
7.6.4 GeneDx Cystic Fibrosis Diagnostic Tests Revenue (US$ Million) & (2019-2024)
7.6.5 GeneDx Recent Developments
7.7 Illumina
7.7.1 Illumina Profile
7.7.2 Illumina Main Business
7.7.3 Illumina Cystic Fibrosis Diagnostic Tests Products, Services and Solutions
7.7.4 Illumina Cystic Fibrosis Diagnostic Tests Revenue (US$ Million) & (2019-2024)
7.7.5 Illumina Recent Developments
7.8 Elucigene Diagnostics
7.8.1 Elucigene Diagnostics Profile
7.8.2 Elucigene Diagnostics Main Business
7.8.3 Elucigene Diagnostics Cystic Fibrosis Diagnostic Tests Products, Services and Solutions
7.8.4 Elucigene Diagnostics Cystic Fibrosis Diagnostic Tests Revenue (US$ Million) & (2019-2024)
7.8.5 Elucigene Diagnostics Recent Developments
7.9 BillionToOne Inc.
7.9.1 BillionToOne Inc. Profile
7.9.2 BillionToOne Inc. Main Business
7.9.3 BillionToOne Inc. Cystic Fibrosis Diagnostic Tests Products, Services and Solutions
7.9.4 BillionToOne Inc. Cystic Fibrosis Diagnostic Tests Revenue (US$ Million) & (2019-2024)
7.9.5 BillionToOne Inc. Recent Developments
7.10 ELITechGroup
7.10.1 ELITechGroup Profile
7.10.2 ELITechGroup Main Business
7.10.3 ELITechGroup Cystic Fibrosis Diagnostic Tests Products, Services and Solutions
7.10.4 ELITechGroup Cystic Fibrosis Diagnostic Tests Revenue (US$ Million) & (2019-2024)
7.10.5 ELITechGroup Recent Developments
8 Industry Chain Analysis
8.1 Cystic Fibrosis Diagnostic Tests Industrial Chain
8.2 Cystic Fibrosis Diagnostic Tests Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Cystic Fibrosis Diagnostic Tests Sales Model
8.5.2 Sales Channel
8.5.3 Cystic Fibrosis Diagnostic Tests Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables Table 1. Cystic Fibrosis Diagnostic Tests Market Trends Table 2. Cystic Fibrosis Diagnostic Tests Market Drivers & Opportunity Table 3. Cystic Fibrosis Diagnostic Tests Market Challenges Table 4. Cystic Fibrosis Diagnostic Tests Market Restraints Table 5. Global Cystic Fibrosis Diagnostic Tests Revenue by Company (2019-2024) & (US$ Million) Table 6. Global Cystic Fibrosis Diagnostic Tests Revenue Market Share by Company (2019-2024) Table 7. Key Companies Cystic Fibrosis Diagnostic Tests Manufacturing Base Distribution and Headquarters Table 8. Key Companies Cystic Fibrosis Diagnostic Tests Product Type Table 9. Key Companies Time to Begin Mass Production of Cystic Fibrosis Diagnostic Tests Table 10. Global Cystic Fibrosis Diagnostic Tests Companies Market Concentration Ratio (CR5 and HHI) Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cystic Fibrosis Diagnostic Tests as of 2023) Table 12. Mergers & Acquisitions, Expansion Plans Table 13. Global Cystic Fibrosis Diagnostic Tests Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million) Table 14. Global Cystic Fibrosis Diagnostic Tests Sales Value by Type (2019-2024) & (US$ Million) Table 15. Global Cystic Fibrosis Diagnostic Tests Sales Value by Type (2025-2030) & (US$ Million) Table 16. Global Cystic Fibrosis Diagnostic Tests Sales Market Share in Value by Type (2019-2024) & (%) Table 17. Global Cystic Fibrosis Diagnostic Tests Sales Market Share in Value by Type (2025-2030) & (%) Table 18. Global Cystic Fibrosis Diagnostic Tests Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million) Table 19. Global Cystic Fibrosis Diagnostic Tests Sales Value by Application (2019-2024) & (US$ Million) Table 20. Global Cystic Fibrosis Diagnostic Tests Sales Value by Application (2025-2030) & (US$ Million) Table 21. Global Cystic Fibrosis Diagnostic Tests Sales Market Share in Value by Application (2019-2024) & (%) Table 22. Global Cystic Fibrosis Diagnostic Tests Sales Market Share in Value by Application (2025-2030) & (%) Table 23. Global Cystic Fibrosis Diagnostic Tests Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million) Table 24. Global Cystic Fibrosis Diagnostic Tests Sales Value by Region (2019-2024) & (US$ Million) Table 25. Global Cystic Fibrosis Diagnostic Tests Sales Value by Region (2025-2030) & (US$ Million) Table 26. Global Cystic Fibrosis Diagnostic Tests Sales Value by Region (2019-2024) & (%) Table 27. Global Cystic Fibrosis Diagnostic Tests Sales Value by Region (2025-2030) & (%) Table 28. Key Countries/Regions Cystic Fibrosis Diagnostic Tests Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030 Table 29. Key Countries/Regions Cystic Fibrosis Diagnostic Tests Sales Value, (2019-2024) & (US$ Million) Table 30. Key Countries/Regions Cystic Fibrosis Diagnostic Tests Sales Value, (2025-2030) & (US$ Million) Table 31. Quidel Corporation Basic Information List Table 32. Quidel Corporation Description and Business Overview Table 33. Quidel Corporation Cystic Fibrosis Diagnostic Tests Products, Services and Solutions Table 34. Revenue (US$ Million) in Cystic Fibrosis Diagnostic Tests Business of Quidel Corporation (2019-2024) Table 35. Quidel Corporation Recent Developments Table 36. Quest Diagnostics Basic Information List Table 37. Quest Diagnostics Description and Business Overview Table 38. Quest Diagnostics Cystic Fibrosis Diagnostic Tests Products, Services and Solutions Table 39. Revenue (US$ Million) in Cystic Fibrosis Diagnostic Tests Business of Quest Diagnostics (2019-2024) Table 40. Quest Diagnostics Recent Developments Table 41. Creative Diagnostics Basic Information List Table 42. Creative Diagnostics Description and Business Overview Table 43. Creative Diagnostics Cystic Fibrosis Diagnostic Tests Products, Services and Solutions Table 44. Revenue (US$ Million) in Cystic Fibrosis Diagnostic Tests Business of Creative Diagnostics (2019-2024) Table 45. Creative Diagnostics Recent Developments Table 46. Invitae Corporation Basic Information List Table 47. Invitae Corporation Description and Business Overview Table 48. Invitae Corporation Cystic Fibrosis Diagnostic Tests Products, Services and Solutions Table 49. Revenue (US$ Million) in Cystic Fibrosis Diagnostic Tests Business of Invitae Corporation (2019-2024) Table 50. Invitae Corporation Recent Developments Table 51. Asper Biogene Basic Information List Table 52. Asper Biogene Description and Business Overview Table 53. Asper Biogene Cystic Fibrosis Diagnostic Tests Products, Services and Solutions Table 54. Revenue (US$ Million) in Cystic Fibrosis Diagnostic Tests Business of Asper Biogene (2019-2024) Table 55. Asper Biogene Recent Developments Table 56. GeneDx Basic Information List Table 57. GeneDx Description and Business Overview Table 58. GeneDx Cystic Fibrosis Diagnostic Tests Products, Services and Solutions Table 59. Revenue (US$ Million) in Cystic Fibrosis Diagnostic Tests Business of GeneDx (2019-2024) Table 60. GeneDx Recent Developments Table 61. Illumina Basic Information List Table 62. Illumina Description and Business Overview Table 63. Illumina Cystic Fibrosis Diagnostic Tests Products, Services and Solutions Table 64. Revenue (US$ Million) in Cystic Fibrosis Diagnostic Tests Business of Illumina (2019-2024) Table 65. Illumina Recent Developments Table 66. Elucigene Diagnostics Basic Information List Table 67. Elucigene Diagnostics Description and Business Overview Table 68. Elucigene Diagnostics Cystic Fibrosis Diagnostic Tests Products, Services and Solutions Table 69. Revenue (US$ Million) in Cystic Fibrosis Diagnostic Tests Business of Elucigene Diagnostics (2019-2024) Table 70. Elucigene Diagnostics Recent Developments Table 71. BillionToOne Inc. Basic Information List Table 72. BillionToOne Inc. Description and Business Overview Table 73. BillionToOne Inc. Cystic Fibrosis Diagnostic Tests Products, Services and Solutions Table 74. Revenue (US$ Million) in Cystic Fibrosis Diagnostic Tests Business of BillionToOne Inc. (2019-2024) Table 75. BillionToOne Inc. Recent Developments Table 76. ELITechGroup Basic Information List Table 77. ELITechGroup Description and Business Overview Table 78. ELITechGroup Cystic Fibrosis Diagnostic Tests Products, Services and Solutions Table 79. Revenue (US$ Million) in Cystic Fibrosis Diagnostic Tests Business of ELITechGroup (2019-2024) Table 80. ELITechGroup Recent Developments Table 81. Key Raw Materials Lists Table 82. Raw Materials Key Suppliers Lists Table 83. Cystic Fibrosis Diagnostic Tests Downstream Customers Table 84. Cystic Fibrosis Diagnostic Tests Distributors List Table 85. Research Programs/Design for This Report Table 86. Key Data Information from Secondary Sources Table 87. Key Data Information from Primary Sources Table 88. Business Unit and Senior & Team Lead Analysts List of Figures Figure 1. Cystic Fibrosis Diagnostic Tests Product Picture Figure 2. Global Cystic Fibrosis Diagnostic Tests Sales Value, 2019 VS 2023 VS 2030 (US$ Million) Figure 3. Global Cystic Fibrosis Diagnostic Tests Sales Value (2019-2030) & (US$ Million) Figure 4. Cystic Fibrosis Diagnostic Tests Report Years Considered Figure 5. Global Cystic Fibrosis Diagnostic Tests Players Revenue Ranking (2023) & (US$ Million) Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Cystic Fibrosis Diagnostic Tests Revenue in 2023 Figure 7. Cystic Fibrosis Diagnostic Tests Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023 Figure 8. Genetic Tests Picture Figure 9. Fecal Test Picture Figure 10. Immunoreactive Trypsinogen (IRT) Test Picture Figure 11. Sweat Chloride Tests Picture Figure 12. Pulmonary Function Tests Picture Figure 13. Global Cystic Fibrosis Diagnostic Tests Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million) Figure 14. Global Cystic Fibrosis Diagnostic Tests Sales Value Market Share by Type, 2023 & 2030 Figure 15. Product Picture of Hospitals Figure 16. Product Picture of Diagnostic Laboratories Figure 17. Product Picture of Others Figure 18. Global Cystic Fibrosis Diagnostic Tests Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million) Figure 19. Global Cystic Fibrosis Diagnostic Tests Sales Value Market Share by Application, 2023 & 2030 Figure 20. North America Cystic Fibrosis Diagnostic Tests Sales Value (2019-2030) & (US$ Million) Figure 21. North America Cystic Fibrosis Diagnostic Tests Sales Value by Country (%), 2023 VS 2030 Figure 22. Europe Cystic Fibrosis Diagnostic Tests Sales Value (2019-2030) & (US$ Million) Figure 23. Europe Cystic Fibrosis Diagnostic Tests Sales Value by Country (%), 2023 VS 2030 Figure 24. Asia Pacific Cystic Fibrosis Diagnostic Tests Sales Value (2019-2030) & (US$ Million) Figure 25. Asia Pacific Cystic Fibrosis Diagnostic Tests Sales Value by Country (%), 2023 VS 2030 Figure 26. South America Cystic Fibrosis Diagnostic Tests Sales Value (2019-2030) & (US$ Million) Figure 27. South America Cystic Fibrosis Diagnostic Tests Sales Value by Country (%), 2023 VS 2030 Figure 28. Middle East & Africa Cystic Fibrosis Diagnostic Tests Sales Value (2019-2030) & (US$ Million) Figure 29. Middle East & Africa Cystic Fibrosis Diagnostic Tests Sales Value by Country (%), 2023 VS 2030 Figure 30. Key Countries/Regions Cystic Fibrosis Diagnostic Tests Sales Value (%), (2019-2030) Figure 31. United States Cystic Fibrosis Diagnostic Tests Sales Value, (2019-2030) & (US$ Million) Figure 32. United States Cystic Fibrosis Diagnostic Tests Sales Value by Type (%), 2023 VS 2030 Figure 33. United States Cystic Fibrosis Diagnostic Tests Sales Value by Application (%), 2023 VS 2030 Figure 34. Europe Cystic Fibrosis Diagnostic Tests Sales Value, (2019-2030) & (US$ Million) Figure 35. Europe Cystic Fibrosis Diagnostic Tests Sales Value by Type (%), 2023 VS 2030 Figure 36. Europe Cystic Fibrosis Diagnostic Tests Sales Value by Application (%), 2023 VS 2030 Figure 37. China Cystic Fibrosis Diagnostic Tests Sales Value, (2019-2030) & (US$ Million) Figure 38. China Cystic Fibrosis Diagnostic Tests Sales Value by Type (%), 2023 VS 2030 Figure 39. China Cystic Fibrosis Diagnostic Tests Sales Value by Application (%), 2023 VS 2030 Figure 40. Japan Cystic Fibrosis Diagnostic Tests Sales Value, (2019-2030) & (US$ Million) Figure 41. Japan Cystic Fibrosis Diagnostic Tests Sales Value by Type (%), 2023 VS 2030 Figure 42. Japan Cystic Fibrosis Diagnostic Tests Sales Value by Application (%), 2023 VS 2030 Figure 43. South Korea Cystic Fibrosis Diagnostic Tests Sales Value, (2019-2030) & (US$ Million) Figure 44. South Korea Cystic Fibrosis Diagnostic Tests Sales Value by Type (%), 2023 VS 2030 Figure 45. South Korea Cystic Fibrosis Diagnostic Tests Sales Value by Application (%), 2023 VS 2030 Figure 46. Southeast Asia Cystic Fibrosis Diagnostic Tests Sales Value, (2019-2030) & (US$ Million) Figure 47. Southeast Asia Cystic Fibrosis Diagnostic Tests Sales Value by Type (%), 2023 VS 2030 Figure 48. Southeast Asia Cystic Fibrosis Diagnostic Tests Sales Value by Application (%), 2023 VS 2030 Figure 49. India Cystic Fibrosis Diagnostic Tests Sales Value, (2019-2030) & (US$ Million) Figure 50. India Cystic Fibrosis Diagnostic Tests Sales Value by Type (%), 2023 VS 2030 Figure 51. India Cystic Fibrosis Diagnostic Tests Sales Value by Application (%), 2023 VS 2030 Figure 52. Cystic Fibrosis Diagnostic Tests Industrial Chain Figure 53. Cystic Fibrosis Diagnostic Tests Manufacturing Cost Structure Figure 54. Channels of Distribution (Direct Sales, and Distribution) Figure 55. Bottom-up and Top-down Approaches for This Report Figure 56. Data Triangulation